144 ·Filed Jun 4, 2026

STE

STERIS plc
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001921094-26-000604
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, low-ratio sell-to-cover transaction tied to vesting RSUs — not a discretionary market sale. It should have no material price impact. Monitor upcoming Form 4 filings to confirm actual execution; if volumes far exceed the stated 3,054 shares, that would be a deviation from this notice.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
STE ▲ +9.44% at T+60d
NEUTRAL call ✓ call won +9.44% · α vs SPY +5.44% · entry $212.35 → $232.39
Entry anchored
Jun 4, 2026
via day open
T+1d
-1.09%
call -1.09% · α -1.32%
$210.03
settled 4mo ago
T+5d
-2.26%
call -2.26% · α -2.83%
$207.56
settled 4mo ago
T+20d
+0.44%
call +0.44% · α -1.42%
$213.28
settled 3mo ago
T+60d
+9.44%
call +9.44% · α +5.44%
$232.39
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice to sell 3,054 ordinary shares currently held via restricted stock units that vested on May 31, 2026. At the filing date, the estimated aggregate market value of the sale is approximately $655,511, based on a valuation of $214.67 per share. This is a pre-scheduled, tax-related insider sale tied to a compensation vesting event, not a discretionary open-market sale.

Key Facts

  • Filer: Daniel A. Carestio, identified as both Officer and Director in the filing.
  • Security: 3,054 ordinary shares from restricted stock that lapsed/vested on May 31, 2026.
  • Estimated market value: $655,511 (based on 06/04/2026 date).
  • Shares are to be sold via Charles Schwab & Co., Inc. on NYSE.
  • No open-market purchase by the insider contemporaneously; this is a pure sell-to-cover or tax-related disposition.
  • Filing date: June 4, 2026.

Financial Impact

Proceeds up to ~$655,511 from sale of 3,054 shares, representing less than 0.01% of $20.5B market cap.

insider holdings

Risk Factors

  • insider selling

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001921094-26-000604
Document: 0001921094-26-000604-index.html0001921094-26-000604
Document: 0001921094-26-000604.txt0001921094-26-000604
10 reports for STE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for STE — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
Press Release
NEUTRAL ★ 2/10
$230.34 $236.44▲ +2.65%▼ −0.73%$208.54 (−9.46%)
Jun 15, 2026
15w ago
144
NEUTRAL ★ 2/10
$206.51 $208.73▲ +1.07%▲ +0.88%$208.54 (+0.98%)
Jun 11, 2026
16w ago
DEFA14A
NEUTRAL ★ 2/10
$207.56 $216.00▲ +4.07%▲ +2.29%$208.54 (+0.47%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$212.88 $215.39▲ +1.18%▼ −0.27%$208.54 (−2.04%)
Jun 5, 2026
17w ago
144
NEUTRAL ★ 2/10
$210.03 $213.28▲ +1.55%▼ −0.08%$208.54 (−0.71%)
Jun 4, 2026
17w ago
144
NEUTRAL ★ 2/10
$212.35 $213.28▲ +0.44%▼ −1.42%$208.54 (−1.79%)
May 11, 2026
20w ago
8-K
BEARISH ★ 7/10
$210.23 $208.10▲ +1.01%▼ −0.71%$208.54 (+0.80%)
May 11, 2026
20w ago
Press Release
MIXED ★ 6/10
$210.23 $208.10▼ −1.01%▲ +0.71%$208.54 (−0.80%)
May 7, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$207.24 $212.35▲ +2.47%▲ +2.44%$208.54 (+0.63%)
Apr 21, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$222.61 $214.42▼ −3.68%▼ −6.84%$208.54 (−6.32%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (64h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access